To identify the potential influences of PrP106–126 on MAP2 levels in the cultured cells, human neuroblastoma cells SK-N-SH were exposed to different amounts of PrP106–126 or scrambled PrP106–126 (SCR). The gene discussed is MAP2; the disease is neuroblastoma.